vs
Side-by-side financial comparison of Incyte (INCY) and ZIONS BANCORPORATION, NATIONAL ASSOCIATION (ZION). Click either name above to swap in a different company.
Incyte is the larger business by last-quarter revenue ($1.3B vs $891.0M, roughly 1.4× ZIONS BANCORPORATION, NATIONAL ASSOCIATION). ZIONS BANCORPORATION, NATIONAL ASSOCIATION runs the higher net margin — 29.5% vs 23.8%, a 5.7% gap on every dollar of revenue. On growth, Incyte posted the faster year-over-year revenue change (20.9% vs 8.7%). Over the past eight quarters, Incyte's revenue compounded faster (10.4% CAGR vs 9.6%).
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Zions Bancorporation is an American national bank headquartered in Salt Lake City, Utah. It operates as a national bank rather than as a bank holding company and does business under the following seven brands: Zions Bank, Amegy Bank of Texas, California Bank and Trust, National Bank of Arizona, Nevada State Bank, Vectra Bank Colorado, and the Commerce Bank of Washington.
INCY vs ZION — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $891.0M |
| Net Profit | $303.3M | $263.0M |
| Gross Margin | — | — |
| Operating Margin | 23.7% | — |
| Net Margin | 23.8% | 29.5% |
| Revenue YoY | 20.9% | 8.7% |
| Net Profit YoY | 91.7% | 21.8% |
| EPS (diluted) | $1.47 | $1.77 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.5B | $891.0M | ||
| Q3 25 | $1.4B | $861.0M | ||
| Q2 25 | $1.2B | $838.0M | ||
| Q1 25 | $1.1B | $795.0M | ||
| Q4 24 | $1.2B | $820.0M | ||
| Q3 24 | $1.1B | $792.0M | ||
| Q2 24 | $1.0B | $777.0M |
| Q1 26 | $303.3M | — | ||
| Q4 25 | $299.3M | $263.0M | ||
| Q3 25 | $424.2M | $222.0M | ||
| Q2 25 | $405.0M | $244.0M | ||
| Q1 25 | $158.2M | $170.0M | ||
| Q4 24 | $201.2M | $216.0M | ||
| Q3 24 | $106.5M | $214.0M | ||
| Q2 24 | $-444.6M | $201.0M |
| Q1 26 | — | — | ||
| Q4 25 | 92.0% | — | ||
| Q3 25 | 92.8% | — | ||
| Q2 25 | 93.5% | — | ||
| Q1 25 | 93.0% | — | ||
| Q4 24 | 92.5% | — | ||
| Q3 24 | 92.4% | — | ||
| Q2 24 | 92.7% | — |
| Q1 26 | 23.7% | — | ||
| Q4 25 | 22.3% | — | ||
| Q3 25 | 32.5% | — | ||
| Q2 25 | 43.6% | — | ||
| Q1 25 | 19.5% | — | ||
| Q4 24 | 25.6% | — | ||
| Q3 24 | 12.8% | — | ||
| Q2 24 | -45.8% | — |
| Q1 26 | 23.8% | — | ||
| Q4 25 | 19.9% | 29.5% | ||
| Q3 25 | 31.1% | 25.8% | ||
| Q2 25 | 33.3% | 29.1% | ||
| Q1 25 | 15.0% | 21.4% | ||
| Q4 24 | 17.1% | 26.3% | ||
| Q3 24 | 9.4% | 27.0% | ||
| Q2 24 | -42.6% | 25.9% |
| Q1 26 | $1.47 | — | ||
| Q4 25 | $1.46 | $1.77 | ||
| Q3 25 | $2.11 | $1.48 | ||
| Q2 25 | $2.04 | $1.63 | ||
| Q1 25 | $0.80 | $1.13 | ||
| Q4 24 | $0.90 | $1.34 | ||
| Q3 24 | $0.54 | $1.37 | ||
| Q2 24 | $-2.04 | $1.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | $1.5B |
| Stockholders' EquityBook value | $5.6B | $7.2B |
| Total Assets | $7.3B | $89.0B |
| Debt / EquityLower = less leverage | — | 0.21× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.1B | — | ||
| Q3 25 | $2.5B | — | ||
| Q2 25 | $2.0B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $987.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $970.0M | ||
| Q1 25 | — | $964.0M | ||
| Q4 24 | — | $950.0M | ||
| Q3 24 | — | $548.0M | ||
| Q2 24 | — | $546.0M |
| Q1 26 | $5.6B | — | ||
| Q4 25 | $5.2B | $7.2B | ||
| Q3 25 | $4.7B | $6.9B | ||
| Q2 25 | $4.2B | $6.6B | ||
| Q1 25 | $3.7B | $6.3B | ||
| Q4 24 | $3.4B | $6.1B | ||
| Q3 24 | $3.2B | $6.4B | ||
| Q2 24 | $3.0B | $6.0B |
| Q1 26 | $7.3B | — | ||
| Q4 25 | $7.0B | $89.0B | ||
| Q3 25 | $6.3B | $88.5B | ||
| Q2 25 | $5.8B | $88.9B | ||
| Q1 25 | $5.7B | $88.0B | ||
| Q4 24 | $5.4B | $88.8B | ||
| Q3 24 | $5.0B | $87.0B | ||
| Q2 24 | $4.7B | $87.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | 0.16× | ||
| Q3 24 | — | 0.09× | ||
| Q2 24 | — | 0.09× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $1.1B |
| Free Cash FlowOCF − Capex | — | $952.0M |
| FCF MarginFCF / Revenue | — | 106.8% |
| Capex IntensityCapex / Revenue | — | 13.6% |
| Cash ConversionOCF / Net Profit | — | 4.08× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.4B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $543.3M | $1.1B | ||
| Q3 25 | $559.4M | $438.0M | ||
| Q2 25 | $44.7M | $-62.0M | ||
| Q1 25 | $266.1M | $179.0M | ||
| Q4 24 | $381.2M | $1.1B | ||
| Q3 24 | $310.9M | $119.0M | ||
| Q2 24 | $-575.6M | $251.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $952.0M | ||
| Q3 25 | — | $413.0M | ||
| Q2 25 | — | $-93.0M | ||
| Q1 25 | — | $152.0M | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $97.0M | ||
| Q2 24 | — | $234.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 106.8% | ||
| Q3 25 | — | 48.0% | ||
| Q2 25 | — | -11.1% | ||
| Q1 25 | — | 19.1% | ||
| Q4 24 | — | 128.2% | ||
| Q3 24 | — | 12.2% | ||
| Q2 24 | — | 30.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 13.6% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | 3.4% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | 2.2% |
| Q1 26 | — | — | ||
| Q4 25 | 1.82× | 4.08× | ||
| Q3 25 | 1.32× | 1.97× | ||
| Q2 25 | 0.11× | -0.25× | ||
| Q1 25 | 1.68× | 1.05× | ||
| Q4 24 | 1.89× | 5.31× | ||
| Q3 24 | 2.92× | 0.56× | ||
| Q2 24 | — | 1.25× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
